Literature DB >> 26310582

Diffusion-weighted imaging of breast tumours at 3 Tesla and 7 Tesla: a comparison.

S Gruber1,2, L Minarikova1,2, K Pinker3, O Zaric1,2, M Chmelik1,2, B Strasser1,2, P Baltzer3, T Helbich3, S Trattnig4,5, W Bogner1,2.   

Abstract

OBJECTIVES: To compare bilateral diffusion-weighted MR imaging (DWI) at 3 T and 7 T in the same breast tumour patients.
METHODS: Twenty-eight patients were included in this IRB-approved study (mean age 56 ± 16 years). Before contrast-enhanced imaging, bilateral DWI with b = 0 and 850 s/mm(2) was performed in 2:56 min (3 T) and 3:48 min (7 T), using readout-segmented echo planar imaging (rs-EPI) with a 1.4 × 1.4 mm(2) (3 T)/0.9 × 0.9 mm(2) (7 T) in-plane resolution. Apparent diffusion coefficients (ADC), signal-to-noise (SNR) and contrast-to-noise ratios (CNR) were assessed.
RESULTS: Twenty-eight lesions were detected (18 malignant, 10 benign). CNR and SNR were comparable at both field strengths (p > 0.3). Mean ADC values at 7 T were 4-22% lower than at 3 T (p ≤ 0.03). An ADC threshold of 1.275 × 10(-3) mm(2)/s resulted in a diagnostic specificity of 90% at both field strengths. The sensitivity was 94% and 100% at 3 T and 7 T, respectively.
CONCLUSION: 7-T DWI of the breast can be performed with 2.4-fold higher spatial resolution than 3 T, without significant differences in SNR if compared to 3 T. KEY POINTS: • 7 T provides a 2.4-fold higher resolution in breast DWI than 3 T • 7 T DWI has a high diagnostic accuracy comparable to that at 3 T • At 7 T malignant lesions had 22 % lower ADC than at 3 T (p < 0.001).

Entities:  

Keywords:  7 Tesla; Breast MRI; Breast cancer; DWI; Diffusion

Mesh:

Year:  2015        PMID: 26310582     DOI: 10.1007/s00330-015-3947-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  40 in total

1.  The role of MRI in invasive lobular carcinoma.

Authors:  Carla Boetes; Jeroen Veltman; Lya van Die; Peter Bult; Theo Wobbes; Jelle O Barentsz
Journal:  Breast Cancer Res Treat       Date:  2004-07       Impact factor: 4.872

2.  Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T.

Authors:  K Pinker; W Bogner; P Baltzer; S Trattnig; S Gruber; O Abeyakoon; M Bernathova; O Zaric; P Dubsky; Z Bago-Horvath; M Weber; D Leithner; T H Helbich
Journal:  Eur Radiol       Date:  2013-12-05       Impact factor: 5.315

3.  Breast DWI at 3 T: influence of the fat-suppression technique on image quality and diagnostic performance.

Authors:  Luisa Nogueira; Sofia Brandão; Rita G Nunes; Hugo Alexandre Ferreira; Joana Loureiro; Isabel Ramos
Journal:  Clin Radiol       Date:  2014-12-30       Impact factor: 2.350

4.  Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.

Authors:  Katja Pinker; Wolfgang Bogner; Pascal Baltzer; Stephan Gruber; Hubert Bickel; Benedikt Brueck; Siegfried Trattnig; Michael Weber; Peter Dubsky; Zsuzsanna Bago-Horvath; Rupert Bartsch; Thomas H Helbich
Journal:  Invest Radiol       Date:  2014-06       Impact factor: 6.016

5.  Readout-segmented echo-planar imaging improves the diagnostic performance of diffusion-weighted MR breast examinations at 3.0 T.

Authors:  Wolfgang Bogner; Katja Pinker-Domenig; Hubert Bickel; Marek Chmelik; Michael Weber; Thomas H Helbich; Siegfried Trattnig; Stephan Gruber
Journal:  Radiology       Date:  2012-04       Impact factor: 11.105

Review 6.  Sensitivity of enhanced MRI for the detection of breast cancer: new, multicentric, residual, and recurrent.

Authors:  P L Davis; K S McCarty
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

7.  Advanced MR methods at ultra-high field (7 Tesla) for clinical musculoskeletal applications.

Authors:  Siegfried Trattnig; Stefan Zbýň; Benjamin Schmitt; Klaus Friedrich; Vladimir Juras; Pavol Szomolanyi; Wolfgang Bogner
Journal:  Eur Radiol       Date:  2012-06-12       Impact factor: 5.315

8.  Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes.

Authors:  Matthias Benndorf; Pascal A T Baltzer; Tibor Vag; Mieczyslaw Gajda; Ingo B Runnebaum; Werner A Kaiser
Journal:  Acta Radiol       Date:  2010-09       Impact factor: 1.990

Review 9.  Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions.

Authors:  S H Heywang-Köbrunner; P Viehweg; A Heinig; C Küchler
Journal:  Eur J Radiol       Date:  1997-02       Impact factor: 3.528

10.  Scan time reduction for readout-segmented EPI using simultaneous multislice acceleration: Diffusion-weighted imaging at 3 and 7 Tesla.

Authors:  Robert Frost; Peter Jezzard; Gwenaëlle Douaud; Stuart Clare; David A Porter; Karla L Miller
Journal:  Magn Reson Med       Date:  2014-07-30       Impact factor: 4.668

View more
  4 in total

Review 1.  The potential of multiparametric MRI of the breast.

Authors:  Katja Pinker; Thomas H Helbich; Elizabeth A Morris
Journal:  Br J Radiol       Date:  2016-11-02       Impact factor: 3.039

2.  Diffusion-weighted imaging of breast lesions: Region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values.

Authors:  Hubert Bickel; Katja Pinker; Stephan Polanec; Heinrich Magometschnigg; Georg Wengert; Claudio Spick; Wolfgang Bogner; Zsuzsanna Bago-Horvath; Thomas H Helbich; Pascal Baltzer
Journal:  Eur Radiol       Date:  2016-08-30       Impact factor: 5.315

Review 3.  Diffusion-weighted breast MRI: Clinical applications and emerging techniques.

Authors:  Savannah C Partridge; Noam Nissan; Habib Rahbar; Averi E Kitsch; Eric E Sigmund
Journal:  J Magn Reson Imaging       Date:  2016-09-30       Impact factor: 4.813

Review 4.  Diffusion Breast MRI: Current Standard and Emerging Techniques.

Authors:  Ashley M Mendez; Lauren K Fang; Claire H Meriwether; Summer J Batasin; Stéphane Loubrie; Ana E Rodríguez-Soto; Rebecca A Rakow-Penner
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.